Global Molecular Diagnostics Market Scrutinized in Koncept Analytics Report Recently Published at

08 Jul 2015 • by Natalie Aster

LONDON – Currently, molecular diagnostics is made use of in reference labs, blood banks as well as hospitals. Infectious diseases form the swiftest growing segment in the molecular diagnostics universe, while the demand from the point-of-care field is also increasing.

Growth of the molecular diagnostics marketplace is ignited by a number of factors, such as growing awareness and acceptance of personalized medicine, technological developments, rising incidence of infectious and chronic diseases, population ageing, and more. Regulatory issues and challenges related to genetic diagnostics are some of the factors restraining the market growth. 

Qiagen, Novartis and Abbott Laboratories are amongst key market players.

Cutting-edge research report “Global Molecular Diagnostics Market Report: 2015 Edition” worked out by Koncept Analytics offers an up-close look at the molecular diagnostics marketplace. The study contains a detailed overview of the global market and delves deep into performance of market segments. It explores industry trends and developments and examines growth drivers. The report investigates market issues and challenges, besides scrutinizing the competitive landscape. The research study also profiles top companies.

Report Details:

Global Molecular Diagnostics Market Report: 2015 Edition
Published: June, 2015
Pages: 48
Price: US$ 700.00

More insightful reports by the publisher can be found at Koncept Analytics page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970